NIH plans to shrink the share of grant applications it will award for the remainder of the fiscal year, in some cases by more ...

The landscape of cancer therapeutics is rapidly evolving with the emergence of sophisticated biologics designed to deliver highly targeted and potent ...

Drug repurposing - identifying new uses for existing medications- has emerged as a transformative approach in oncology, offering a cost-effective and ...

An international seminar on biomedical research was held at Kakatiya Government Degree College, Hanamkonda, featuring global ...

From humble beginnings, the University of Colorado Cancer Center has grown into a leading center for research, clinical care, ...

Tobacco use is a modifiable risk factor attributed to an increased risk for many cancers, including esophageal cancer. What ...

Kakatiya Government College, Hanamkonda, hosted an international seminar on biomedical research with global experts ...

Revolutionize your oncology strategy with the CAR/TCR/TIL Therapies in Oncology Analytical Tool. Navigate the fast-evolving cancer treatment landscape, uncovering 236 new therapies and 5,021 events.

BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced its Chief Scientific Officer, Alan Korman, Ph.D. is the 2025 recipient of one of the ...

A new study published in the journal of Frontiers of Endocrinology revealed that low calcium intake, age at pregnancy, prior ...

Scientists have identified a key gene essential for vitamin D absorption, which may also boost treatments for cancer and ...